Infectious complications of Bio-Alcamid filler used for HIV-related facial lipoatrophy.

@article{Nadarajah2012InfectiousCO,
  title={Infectious complications of Bio-Alcamid filler used for HIV-related facial lipoatrophy.},
  author={Jeya T. Nadarajah and Micaela Collins and Janet M. Raboud and Desheng Su and Kavya I Rao and Mona Loutfy and Sharon Walmsley},
  journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  year={2012},
  volume={55 11},
  pages={1568-74}
}
BACKGROUND Human immunodeficiency virus (HIV)-related facial lipoatrophy is a devastating adverse effect of antiretroviral therapy. At this time, the most viable treatment option is cosmetic surgery with synthetic fillers. Bio-Alcamid has many advantages over other fillers, and has become widely used. The objective of this study was to determine the incidence rate of infectious complications associated with Bio-Alcamid facial filler in patients with HIV-related facial lipoatrophy (FLA… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 4 times over the past 90 days. VIEW TWEETS
6 Citations
41 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 41 references

Long-term efficacy and safety of polyacrylamide hydrogel injection in the treatment of human immunodeficiency virus-related facial lipoatrophy: a 5-year follow-up

  • G De Santis, M Pignatti, A Baccarani
  • Plast Reconstr Surg
  • 2012

Similar Papers

Loading similar papers…